Skip to Content

Avadel Pharmaceuticals PLC ADR AVDL

Morningstar Rating
$11.53 +0.12 (1.05%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AVDL is trading at a 39% discount.
Price
$11.42
Fair Value
$85.45
Uncertainty
Extreme
1-Star Price
$856.64
5-Star Price
$4.25
Economic Moat
Gwqh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AVDL is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$11.41
Day Range
$11.4111.70
52-Week Range
$5.9216.85
Bid/Ask
$10.89 / $11.54
Market Cap
$1.04 Bil
Volume/Avg
268,101 / 577,150

Key Statistics

Price/Earnings (Normalized)
Price/Sales
98.24
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in both the primary care and sterile injectables markets. Its products portfolio includes Bloxiverz, Vazculep (phenylephrine hydrochloride injection), Akovaz (ephedrine sulfate injection), Karbinal ER (carbinoxamine maleate extended-release oral suspension), AcipHex Sprinkle (rabeprazole sodium), Cefaclor for Oral Suspension, 125 mg/5 mL, 250 mg/5 mL and 375 mg/5 mL, and Flexichamber. Majority of the revenue is derived from the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
41

Competitors

    Valuation

    Metric
    AVDL
    Price/Earnings (Normalized)
    Price/Book Value
    9.26
    Price/Sales
    98.24
    Price/Cash Flow
    Price/Earnings
    AVDL

    Financial Strength

    Metric
    AVDL
    Quick Ratio
    2.97
    Current Ratio
    3.19
    Interest Coverage
    −13.76
    Quick Ratio
    AVDL

    Profitability

    Metric
    AVDL
    Return on Assets (Normalized)
    −80.05%
    Return on Equity (Normalized)
    −363.21%
    Return on Invested Capital (Normalized)
    −98.87%
    Return on Assets
    AVDL

    Drug Manufacturers - Specialty & Generic Industry Comparables

    Ticker
    Name
    Morningstar Rating for Stocks
    Economic Moat
    Market Cap
    ZTS
    Zoetis Inc Class AGhvjb$80.7 Bil
    MKKGY
    Merck KGaA ADRRbcsyx$76.7 Bil
    HLN
    Haleon PLC ADRSckb$38.9 Bil
    RDY
    Dr Reddy's Laboratories Ltd ADRQsrs$11.4 Bil
    VTRS
    Viatris IncNjjjq$11.0 Bil
    TEVA
    Teva Pharmaceutical Industries Ltd ADRBfdw$10.8 Bil
    CTLT
    Catalent IncLlgmcc$7.1 Bil
    PRGO
    Perrigo Co PLCZgjz$4.1 Bil
    PBH
    Prestige Consumer Healthcare IncGbhqdr$2.8 Bil
    CURLF
    Curaleaf Holdings IncYcjg$2.7 Bil